| (Values in U.S. Thousands) | Dec, 2011 | Sep, 2011 | Jun, 2011 | Mar, 2011 | Dec, 2010 |
| Sales | 2,416,000 | 2,448,000 | 2,338,000 | 2,283,000 | 2,277,000 |
| Sales Growth | -1.31% | +4.70% | +2.41% | +0.26% | +7.81% |
| Net Income | 521,000 | 465,000 | 404,000 | 355,000 | 414,000 |
| Net Income Growth | +12.04% | +15.10% | +13.80% | -14.25% | -2.82% |
Reckitt Benckiser Group Plc (RKT.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold a number-one or number-two position in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating over 35% of sales from emerging markets.
Fiscal Year End Date: 12/31